کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3930563 1253265 2009 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer
چکیده انگلیسی

Non–muscle-invasive bladder cancer (NMIBC) is characterized by a high risk of recurrence after transurethral resection of an initial tumor; the 1-yr recurrence rate is 15–61%, and the 5-yr recurrence rate is 31–78%. These figures represent the heterogeneous character of NMIBC. The treatment and follow-up (FU) strategy vary depending on initial and subsequent clinical and histopathological characteristics. Clinical prognostic factors for recurrence and progression are size, multiplicity, reaction to intravesical therapy, grade, stage, and the presence of carcinoma in situ. In addition, recurrence anywhere in the bladder at first FU cystoscopy after transurethral resection is one of the most important prognostic factors for time to progression.The major goals in treating patients with NMIBC are to prevent the high number of recurrences and to prevent muscle-invasive progression. In this review, risks of recurrence and progression are analyzed and discussed in separate sections, including clinical and pathological results, applied treatments, and diagnostics. Finally, means and recommendations for FU are discussed.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Urology Supplements - Volume 8, Issue 7, September 2009, Pages 556–562
نویسندگان
, ,